1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow SB-485232: new trials by email Literature Review of SB-485232 trials Research Report on SB-485232
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma SB-485232 - Melanoma | Phase 2 | Completed | GlaxoSmithKline | 64 | 2004-11-15 | 2017-07-27 |
Melanoma (1)
GlaxoSmithKline (1)
Australia (1) · United States (1)